The normal bladder mucosal epithelial cell line SVHUC1 and bladder cancer cell lines (T24, UMUC3) were used to determine the efficiency and specificity of CRISPR-CasΦ driven by NSGEP on knocking down CDK5 expression in bladder cancer cells (Fig. 3C). This evidence concerns the gene CDK5 and urinary bladder carcinoma.